logo
  

FDA Approves Janssen's Tremfya For Treatment Of Adults With Active Psoriatic Arthritis

MorphoSys AG (MOR) Tuesday said that its licensee Janssen Research & Development LLC announced the U.S. Food and Drug Administration approval of Tremfya as a treatment for adult patients living with active psoriatic arthritis.

Active PsA is a chronic progressive disease characterized by painful joints and skin inflammation.

As Janssen announced, the approval of Tremfya was based on results from the Phase 3 studies DISCOVER-1 and DISCOVER-2, which evaluated the efficacy and safety of Tremfya in adults with active PsA compared to placebo.

Dr. Malte Peters, Chief Research and Development Officer of MorphoSys, said: "Active psoriatic arthritis is a high burden for patients, causing limited mobility, pain and fatigue. We are very pleased about the FDA approval for Tremfya(R), providing patients with a new treatment option for this debilitating indication."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
After Disney World, retail giant Walmart Inc. (WMT) makes it mandatory for all its employees to wear mask on their facilities in the "high-risk" states where the Delta variant of Coronavirus has become menacing. The orders will be in effect immediately. The Center for Disease Control and Prevention... Generac Power Systems is recalling 325,735 units of Generac and DR 6500 Watt and 8000 Watt portable generators for potential risk of finger amputation and crushing hazards, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. These include 4,575 units sold in Canada. Omaha, Nebraska- based Greater Omaha Packing is recalling around 295,236 pounds of raw beef products citing the possible presence of E. coli O157:H7, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The raw beef products intended for non-intact use were produced on July 13.
Follow RTT